Inhibrx Biosciences, Inc. INBX Operating Lease Weighted Average Discount Rate Percent
Operating Lease Weighted Average Discount Rate Percent at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent?
- Inhibrx Biosciences, Inc. (INBX) reported operating lease weighted average discount rate percent of $0.1 in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent changed year-over-year?
- Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent decreased by 0.0% year-over-year, from $0.1 to $0.1.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s operating lease weighted average discount rate percent has grown at a 11.5% compound annual growth rate (CAGR), from $0.08 to $0.1.